Compare Stocks
Compare up to 5 stocks side by side with metrics, growth rates, and performance charts
Select Stocks
ALNY
BNTX
Add up to 3 more stocks
ALNY
Alnylam Pharmaceuticals, Inc.
+3.02%
$236.22+6.92At close: Aug 21, 2026, 4:00 PM ET
Market Cap
$31.61B
52W Range
$197.81 - $495.55
BNTX
BioNTech SE
+5.12%
$116.57+5.68At close: Aug 21, 2026, 4:00 PM ET
Market Cap
$29.28B
52W Range
$79.52 - $124.00
| Metric | ||
|---|---|---|
| ValuationTTM multiples, at last close | ||
| P/E Ratio | 39.90 | N/A |
| Forward P/E | 36.30 | N/A |
| P/B Ratio | 24.12 | 1.46 |
| P/S Ratio | 6.80 | 9.53 |
| P/FCF Ratio | 60.19 | 47.73 |
| EV/EBITDA | 30.56 | N/A |
| Profitabilitytrailing twelve months | ||
| Gross Margin | 79.7% | 71.0% |
| Operating Margin | 20.8% | -22.6% |
| Net Margin | 16.8% | -63.0% |
| ROE | 59.7% | -9.6% |
| ROA | 14.5% | -8.4% |
| ROIC | 24.7% | -10.4% |
| Financial Healthlatest reported quarter | ||
| Current Ratio | 3.05 | 7.85 |
| Quick Ratio | 2.99 | 7.80 |
| Debt/Equity | 0.94 | 0.02 |
| Interest Coverage | 1.99 | -45.74 |
| Dividendstrailing dividends vs latest price | ||
| Dividend Yield | N/A | N/A |
| Payout Ratio | N/A | N/A |
| Yrs of Dividend Growth | 0 | 0 |
N/A includes metrics that are structurally not meaningful for a company's sector (e.g. EV multiples, free-cash-flow ratios, and working-capital ratios for banks and insurers). Bars show each value's size relative to the row's largest — a factual magnitude cue, not a rating. Tap a metric name for its full history.